A Common Diabetes Drug May Reduce Long Covid Risk, Trial Data Finds
A Common Diabetes Drug May Reduce Long Covid Risk, Trial Data Finds
Preliminary data from a randomized clinical trial may point to a potential way to prevent long covid. The trial found that covid-19 patients who took metformin, a commonly prescribed diabetes drug, were noticeably less likely to be diagnosed with long covid up to 10 months later than people in the control group. More… Read more…
View On WordPress















